Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States

American Journal of Clinical Nutrition

Volumn 76, Issue 6, 2002, Pages 1256-1260

  Ramakrishnan, Usha ^a   Kuklina, Elena ^b   Stein, Aryeh D ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Anemia; Blood lipids; Cardiovascular disease; Ferritin; Glucose metabolism; Heart disease; Iron status; Iron stores; Lipid metabolism; NHANES III; Premenopausal women; Women

Indexed keywords

CHOLESTEROL; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; TRIACYLGLYCEROL;

ADULT; AGE; ANEMIA; ARTICLE; BLOOD DONOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GLUCOSE METABOLISM; HUMAN; INFECTION; IRON STORAGE; LIPID METABOLISM; MAJOR CLINICAL STUDY; NEGRO; PATIENT SELECTION; PREVALENCE; RACE DIFFERENCE; REPRODUCTION; RISK FACTOR;

EID: 18744376322     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/76.6.1256     Document Type: Article

References (29)

1. Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron Metabolism in Man. Oxford, United Kingdom: Blackwell Scientific Publications, 1979.
2. Miller DK, Hiramatsu N, Perks SM, Miller DD. Dietary vitamin E and C protect against iron induced lipid peroxidation in swine. FASEB J 1995;9:A7976 (abstr).
3. Beard J. Iron-dependent pathologies. In: Earl R, Woteki E, eds. Iron Deficiency Anemia: Recommended Guidelines for Prevention, Detection and Management Among US Children and Women of Childbearing Age. Washington, DC: National Academy Press, 1993:99-111.
4. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. London: WB Saunders, 1994.
5. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: A HUGE review. Human genome epidemiology. Am J Epidemiol 2001;154:193-206.
6. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
7. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-22.
8. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
9. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: The NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10:441-8.
10. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24.
11. Giles WH, Anda RF, Williamson DF, Yip R, Marks J. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;331:1159-60.
12. Stampfer MJ, Grodstein F, Rosenberg I, Willett W, Hennekens C. A prospective study of plasma ferritin and risk of myocardial infarction in US physicians. Circulation 1993;87:688.
13. Tuomainen T-P, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1-10.
14. Alexander RW. Inflammation and coronary heart disease. N Engl J Med 1994;331:468-9.
15. Oshaug A, Bugge KH, Bjonnes CH, Borch-Iohnsen B, Neslein I-L. Associations between serum ferritin and cardiovascular risk factors in healthy young men. A cross sectional study. Eur J Clin Nutr 1995;49:430-8.
16. Herbert V, Shaw S, Jayatilleke E. Serum ferritin-iron (holoferritin): A new test for iron deficiency or excess. FASEB J 1995;9:A974 (abstr).
17. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974;290:1213-6.
18. de Valk B, Marx JJM. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999;159:1-12.
19. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD: Vital and Health Statistics. 1994;1:32.
20. Frohlich ED, Grim C, Labrthe DR, et al. Recommendations for human blood pressure determination by sphygmomanometers. Hypertension 1988;11:210A-22A.
21. Gunter E, Lewis B, Koncikowski S. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
22. SAS Institute Inc. SAS/STAT User's Guide, Version 6 Edition. Cary, NC: SAS Institute Inc, 1990.
23. Shah BV, Barnwell BG, Hunt PN, Nileen P, La Vange LM. SUDAAN User's Manual, Release 5.5. Research Triangle Park, NC: Research Triangle Institute, 1991.
24. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986;68:726-31.
25. Milman N, Kirchhoff M. Relationship between serum ferritin and risk factors for ischaemic heart disease in 2235 Danes aged 30-60 years. J Intern Med 1999;245:423-33.
26. Berge LN, Bonaa KH, Nordoyo A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arterioscler Thromb 1994;14:857-61.
27. Looker AC, Johnson CL, McDowell MA, Yetley EA. Iron status: Prevalence of impairment in three Hispanic groups in the United States. Am J Clin Nutr 1989;49:553-8.
28. From the Centers for Disease Control and Prevention. Update: Prevalence of overweight among children, adolescents, and adults-United States, 1988-1994. JAMA 1997;277:1111.
29. Frith-Terhune A, Cogswell M, Kettel-Khan L, Will J, Ramakrishnan U. Determinants of iron deficiency among Mexican-American and non-Hispanic white females: Third National Health and Nutrition Examination Survey, 1988-94 (NHANES III). Am J Clin Nutr 2000; 74:963-8.